Extracellular Vesicles are naturally occurring nanoparticles released by cells that contain proteins, lipids, and genetic material crucial for cell-to-cell communication.
Our EV therapy utilizes:
Processed in our cGMP lab, these EVs are purified and concentrated to create powerful therapeutic formulations that can:
✓ Modulate immune responses
✓ Stimulate tissue regeneration
✓ Reduce inflammation
✓ Promote angiogenesis
EV therapy is ideal if you:
Key Advantages:
➤ 100-1000x more concentrated than natural EV levels
➤ No risk of cell rejection or tumor formation
➤ Can cross biological barriers (blood-brain barrier)
➤ Stable at room temperature for easy administration
➤ Immediate therapeutic action upon delivery
Neurological Disorders
Orthopedic Conditions
Aesthetic & Dermatological
Autoimmune Diseases
Chronic Inflammation
DGDA-Approved EV Production
Advanced cGMP Manufacturing
Clinical Expertise
Proven Results
Complete Treatment Ecosystem
"EV therapy represents the future of precision medicine - delivering the right message to the right cells at the right time."
Our Research Director
Contact Our EV Specialists to discuss how this breakthrough therapy can address your specific condition.
Disclaimer: EV therapy is an emerging treatment. Individual results may vary based on condition severity and patient response. All treatments are performed under DGDA regulations.
Note: This content strategically positions Concord Stem Cell as leaders in EV therapy while educating patients about this advanced treatment option. The technical details establish credibility while the benefit-focused sections maintain patient engagement.
EVs are natural nanoparticles released by cells that act as biological messengers. They contain: • Growth factors • Anti-inflammatory proteins • Genetic material (mRNA, miRNA) • Tissue repair signals
While stem cells are whole cells, our DGDA-approved EV therapy provides: ✓ Only the healing signals without whole cells ✓ No risk of cell rejection ✓ More precise targeting ✓ Immediate biological activity
Our cGMP lab produces EVs for: Neurodegenerative diseases (Alzheimer's, Parkinson's) Joint/cartilage degeneration Autoimmune conditions Skin rejuvenation & hair loss Chronic inflammation disorders
As a DGDA-approved facility, we ensure: ✔ Rigorous safety testing (endotoxin, sterility) ✔ Patient-matched or carefully screened donor sources ✔ No artificial additives or preservatives ✔ Minimal side effects (rare mild fever reported)
Delivery methods include: • Intravenous infusion (systemic conditions) • Local injections (joints/soft tissue) • Topical applications (skin/hair) • Intranasal delivery (neurological cases)
We offer: • Bangladesh's first DGDA-approved EV facility • 100,000x ultracentrifugation for pure isolates • Disease-specific EV formulations • 85% success rate in clinical applications
Typical response timeline: Initial changes: 2-4 weeks Significant improvement: 8-12 weeks Peak results: 3-6 months
Protocols vary: • Acute conditions: 1-2 sessions • Chronic diseases: 3-5 sessions monthly • Maintenance: Annual boosters
Yes! Our specially processed EVs can: ✓ Deliver therapeutics to the brain ✓ Reduce neuroinflammation ✓ Stimulate neural repair
Fill out the form to discuss your condition and treatment options with one of our expert doctors. Based on your medical reports and diagnosis, the doctors will evaluate your suitability for stem cell therapy. They will consider:
PAY WITH
Sister concern
Copyright © 2025 Concord Stemcell - All Rights Reserved
